Cooper Companies Inc (NYSE:COO) VP Randal Golden sold 1,154 shares of the stock in a transaction dated Wednesday, June 19th. The shares were sold at an average price of $328.16, for a total value of $378,696.64. Following the completion of the transaction, the vice president now directly owns 1,148 shares in the company, valued at approximately $376,727.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Shares of Cooper Companies stock traded up $7.32 during trading hours on Wednesday, hitting $331.51. The company’s stock had a trading volume of 207,248 shares, compared to its average volume of 343,541. Cooper Companies Inc has a 12 month low of $228.65 and a 12 month high of $332.34. The company has a market capitalization of $16.05 billion, a P/E ratio of 28.83, a price-to-earnings-growth ratio of 2.47 and a beta of 0.78. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.21 and a quick ratio of 0.68.
Cooper Companies (NYSE:COO) last posted its quarterly earnings data on Thursday, May 30th. The medical device company reported $2.94 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.76 by $0.18. The business had revenue of $654.30 million during the quarter, compared to the consensus estimate of $655.00 million. Cooper Companies had a return on equity of 17.25% and a net margin of 16.46%. Cooper Companies’s quarterly revenue was up 3.6% on a year-over-year basis. During the same period last year, the company earned $2.86 earnings per share. On average, equities analysts anticipate that Cooper Companies Inc will post 12.24 EPS for the current fiscal year.
Several large investors have recently bought and sold shares of the stock. Nordea Investment Management AB grew its holdings in shares of Cooper Companies by 1.4% during the first quarter. Nordea Investment Management AB now owns 2,598 shares of the medical device company’s stock worth $769,000 after buying an additional 36 shares in the last quarter. Dupont Capital Management Corp grew its holdings in shares of Cooper Companies by 4.4% during the fourth quarter. Dupont Capital Management Corp now owns 881 shares of the medical device company’s stock worth $224,000 after buying an additional 37 shares in the last quarter. Thrivent Financial for Lutherans grew its holdings in shares of Cooper Companies by 1.8% during the fourth quarter. Thrivent Financial for Lutherans now owns 2,141 shares of the medical device company’s stock worth $545,000 after buying an additional 37 shares in the last quarter. Archford Capital Strategies LLC grew its holdings in shares of Cooper Companies by 4.7% during the first quarter. Archford Capital Strategies LLC now owns 942 shares of the medical device company’s stock worth $279,000 after buying an additional 42 shares in the last quarter. Finally, Rehmann Capital Advisory Group grew its holdings in shares of Cooper Companies by 24.3% during the fourth quarter. Rehmann Capital Advisory Group now owns 220 shares of the medical device company’s stock worth $56,000 after buying an additional 43 shares in the last quarter. Institutional investors and hedge funds own 95.96% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Insider Selling: Cooper Companies Inc (NYSE:COO) VP Sells 1,154 Shares of Stock” was published by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4379905/insider-selling-cooper-companies-inc-nysecoo-vp-sells-1154-shares-of-stock.html.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Recommended Story: What is meant by a buy rating?
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.